Intuitive Surgical's Da Vinci Prostatectomy Bolus 'Has Legs,' Barclays Says

By: via Benzinga
Barclays reiterated its Overweight rating on Intuitive Surgical, Inc. (NASDAQ: ISRG) after its urologist survey showed that da Vinci ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.